• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

更正：在需要口服抗凝治疗和经皮冠状动脉介入治疗的患者中，低剂量普拉格雷与氯吡格雷作为三联抗栓治疗一部分的短期临床结局比较。

Correction: Comparison of short-term clinical outcomes between low-dose prasugrel and clopidogrel as part of triple antithrombotic therapy in patients requiring oral anticoagulant therapy and percutaneous coronary intervention.

作者信息

Kitahara Hideki, Tateishi Kazuya, Shiko Yuki, Inaba Yusuke, Kobayashi Yoshio, Inoue Takahiro

出版信息

PLoS One. 2023 Oct 31;18(10):e0293937. doi: 10.1371/journal.pone.0293937. eCollection 2023.

DOI:10.1371/journal.pone.0293937
PMID:37906590
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10617684/
Abstract

[This corrects the article DOI: 10.1371/journal.pone.0272140.].

摘要

[本文更正了文章的数字对象标识符：10.1371/journal.pone.0272140。]

相似文献

1
Correction: Comparison of short-term clinical outcomes between low-dose prasugrel and clopidogrel as part of triple antithrombotic therapy in patients requiring oral anticoagulant therapy and percutaneous coronary intervention.更正：在需要口服抗凝治疗和经皮冠状动脉介入治疗的患者中，低剂量普拉格雷与氯吡格雷作为三联抗栓治疗一部分的短期临床结局比较。
PLoS One. 2023 Oct 31;18(10):e0293937. doi: 10.1371/journal.pone.0293937. eCollection 2023.
2
Comparison of short-term clinical outcomes between low-dose prasugrel and clopidogrel as part of triple antithrombotic therapy in patients requiring oral anticoagulant therapy and percutaneous coronary intervention.比较低剂量普拉格雷和氯吡格雷作为需要口服抗凝治疗和经皮冠状动脉介入治疗的三联抗栓治疗一部分的短期临床结局。
PLoS One. 2022 Jul 28;17(7):e0272140. doi: 10.1371/journal.pone.0272140. eCollection 2022.
3
Safety and Efficacy of Low-Dose Prasugrel as Part of Triple Therapy With Aspirin and Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention　- From the TWMU-AF PCI Registry.替格瑞洛低剂量三联疗法用于接受经皮冠状动脉介入治疗的房颤患者的安全性和疗效 - 来自 TWMCU-AF PCI 注册研究。
Circ J. 2019 Apr 25;83(5):1000-1005. doi: 10.1253/circj.CJ-18-1113. Epub 2019 Mar 27.
4
Dual antithrombotic therapy with oral anticoagulant and P2Y12 inhibitors in patients with atrial fibrillation after percutaneous coronary intervention.经皮冠状动脉介入治疗后合并心房颤动患者的口服抗凝药和 P2Y12 抑制剂双联抗栓治疗。
J Cardiol. 2023 Sep;82(3):207-214. doi: 10.1016/j.jjcc.2023.06.002. Epub 2023 Jun 17.
5
Triple Antithrombotic Therapy With Aspirin, P2Y12 Inhibitor, and Warfarin After Percutaneous Coronary Intervention: An Evaluation of Prasugrel or Ticagrelor Versus Clopidogrel.经皮冠状动脉介入治疗后阿司匹林、P2Y12抑制剂和华法林三联抗栓治疗：普拉格雷或替格瑞洛与氯吡格雷的疗效评估
J Cardiovasc Pharmacol Ther. 2017 Nov;22(6):546-551. doi: 10.1177/1074248417698042. Epub 2017 Mar 9.
6
Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study.经皮冠状动脉介入治疗的急性心肌梗死患者接受口服抗凝和双联抗血小板治疗的结果：来自 TRANSLATE-ACS 研究的氯吡格雷与普拉格雷比较。
JACC Cardiovasc Interv. 2015 Dec 21;8(14):1880-9. doi: 10.1016/j.jcin.2015.08.018.
7
Safety and Efficacy of Triple Therapy With Ticagrelor or Prasugrel Versus Clopidogrel After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction.替格瑞洛或普拉格雷三联疗法与氯吡格雷用于 ST 段抬高型心肌梗死经皮冠状动脉介入治疗后的安全性和疗效。
J Cardiovasc Pharmacol Ther. 2021 Nov;26(6):625-629. doi: 10.1177/10742484211031436. Epub 2021 Jul 8.
8
Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial.在计划进行经皮冠状动脉介入治疗的患者中，普拉格雷与高负荷及维持剂量氯吡格雷的比较：心肌梗死溶栓治疗44试验中普拉格雷与氯吡格雷抑制血小板活化和聚集的比较。
Circulation. 2007 Dec 18;116(25):2923-32. doi: 10.1161/CIRCULATIONAHA.107.740324. Epub 2007 Dec 3.
9
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.房颤合并冠状动脉疾病患者的三联与双联抗栓治疗
Am J Med. 2016 Jun;129(6):592-599.e1. doi: 10.1016/j.amjmed.2015.12.026. Epub 2016 Jan 18.
10
Efficacy and safety of antithrombotic regimens after coronary intervention in patients on oral anticoagulation: Traditional and Bayesian meta-analysis of clinical trials.口服抗凝治疗患者冠状动脉介入术后抗血栓治疗方案的疗效和安全性：传统及贝叶斯临床试验荟萃分析
Int J Cardiol. 2016 Feb 15;205:89-96. doi: 10.1016/j.ijcard.2015.12.005. Epub 2015 Dec 17.

本文引用的文献

1
Comparison of short-term clinical outcomes between low-dose prasugrel and clopidogrel as part of triple antithrombotic therapy in patients requiring oral anticoagulant therapy and percutaneous coronary intervention.比较低剂量普拉格雷和氯吡格雷作为需要口服抗凝治疗和经皮冠状动脉介入治疗的三联抗栓治疗一部分的短期临床结局。
PLoS One. 2022 Jul 28;17(7):e0272140. doi: 10.1371/journal.pone.0272140. eCollection 2022.